Genome & Company (KOSDAQ: 314130)
3,555.00
-145.00 (-3.92%)
Sep 11, 2024, 2:59 PM KST
Genome & Company Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 72,420 | 56,356 | 72,216 | 36,049 | 103,948 | 21,938 |
Short-Term Investments | 6,765 | 18,863 | 28,205 | 35,249 | 5,640 | 3,686 |
Trading Asset Securities | 5,195 | 11,053 | 6,278 | 5,865 | - | 5,000 |
Cash & Short-Term Investments | 84,380 | 86,272 | 106,699 | 77,164 | 109,588 | 30,624 |
Cash Growth | -21.61% | -19.14% | 38.28% | -29.59% | 257.85% | - |
Accounts Receivable | 1,168 | 1,402 | 1,957 | 759.22 | - | - |
Other Receivables | 1,067 | 1,544 | 864.23 | 992.14 | 1,377 | 356.06 |
Receivables | 2,236 | 2,946 | 2,821 | 1,751 | 1,377 | 356.06 |
Inventory | 5,075 | 3,568 | 2,238 | 1,327 | - | - |
Prepaid Expenses | 714.24 | 1,150 | 1,159 | 1,102 | 243.77 | 125.24 |
Other Current Assets | 1,083 | 3,114 | 3,994 | 433.15 | 71.28 | 371.48 |
Total Current Assets | 93,488 | 97,050 | 116,909 | 81,777 | 111,280 | 31,477 |
Property, Plant & Equipment | 36,166 | 34,624 | 21,526 | 16,475 | 4,271 | 2,926 |
Long-Term Investments | - | - | - | - | - | -0 |
Goodwill | 14,133 | 14,133 | 16,458 | 16,458 | 1,063 | - |
Other Intangible Assets | 9,654 | 11,102 | 13,921 | 18,388 | 3,811 | 329.5 |
Other Long-Term Assets | 4,756 | 5,152 | 4,182 | 4,119 | 457.17 | 452.65 |
Total Assets | 158,197 | 162,060 | 172,997 | 137,216 | 120,883 | 35,185 |
Accounts Payable | 1,004 | 340.19 | 205.18 | 321.4 | - | - |
Accrued Expenses | 2,462 | 2,723 | 3,428 | 1,713 | 316.7 | 656.33 |
Short-Term Debt | 12,805 | 11,997 | - | - | - | - |
Current Portion of Leases | 1,078 | 1,055 | 2,024 | 1,583 | 580.26 | 417.76 |
Other Current Liabilities | 7,560 | 12,116 | 5,484 | 6,208 | 2,111 | 64,986 |
Total Current Liabilities | 24,909 | 28,231 | 11,141 | 9,826 | 3,008 | 66,060 |
Long-Term Debt | 10,384 | 9,637 | - | - | - | 5,850 |
Long-Term Leases | 3,441 | 3,764 | 4,267 | 5,243 | 1,179 | 1,132 |
Long-Term Deferred Tax Liabilities | 4,186 | 4,414 | 5,582 | 6,826 | 782.66 | - |
Other Long-Term Liabilities | 2,793 | 2,497 | 1,462 | 1,921 | 830.66 | 114.36 |
Total Liabilities | 45,712 | 48,543 | 22,452 | 23,816 | 5,800 | 73,156 |
Common Stock | 7,643 | 7,363 | 7,046 | 7,033 | 6,652 | 4,113 |
Additional Paid-In Capital | 304,688 | 304,765 | 304,724 | 257,345 | 246,880 | 73,810 |
Retained Earnings | -291,196 | -284,659 | -237,193 | -185,355 | -151,238 | -120,505 |
Comprensive Income & Other | 37,285 | 34,240 | 21,784 | 13,710 | 9,139 | 2,906 |
Total Common Equity | 58,420 | 61,708 | 96,360 | 92,733 | 111,434 | -39,676 |
Minority Interest | 53,541 | 51,089 | 53,248 | 20,667 | 3,371 | - |
Shareholders' Equity | 112,485 | 113,517 | 150,544 | 113,400 | 115,083 | -37,971 |
Total Liabilities & Equity | 158,197 | 162,060 | 172,997 | 137,216 | 120,883 | 35,185 |
Total Debt | 27,708 | 26,453 | 6,291 | 6,826 | 1,759 | 7,399 |
Net Cash (Debt) | 56,672 | 59,819 | 100,408 | 70,338 | 107,829 | 23,225 |
Net Cash Growth | -41.34% | -40.42% | 42.75% | -34.77% | 364.28% | - |
Net Cash Per Share | 1972.81 | 2118.26 | 3566.88 | 2616.46 | 5599.59 | 1448.66 |
Filing Date Shares Outstanding | 15.19 | 29.45 | 28.18 | 28.13 | 26.61 | 16.03 |
Total Common Shares Outstanding | 15.19 | 29.45 | 28.18 | 28.13 | 26.61 | 16.03 |
Working Capital | 68,580 | 68,819 | 105,769 | 71,952 | 108,272 | -34,584 |
Book Value Per Share | 3846.34 | 2095.34 | 3419.08 | 3296.30 | 4187.69 | -2474.79 |
Tangible Book Value | 34,633 | 36,473 | 65,981 | 57,888 | 106,559 | -40,005 |
Tangible Book Value Per Share | 2280.23 | 1238.47 | 2341.16 | 2057.68 | 4004.50 | -2495.34 |
Land | 2,711 | 2,710 | 10.59 | - | - | - |
Buildings | 9,251 | 9,220 | - | - | - | - |
Machinery | 17,599 | 15,838 | 14,662 | 9,167 | 3,026 | 1,498 |
Construction In Progress | 9,333 | 8,492 | 4,245 | 2,262 | 19.45 | 350 |
Source: S&P Capital IQ. Standard template. Financial Sources.